Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms

An Open Study to Assess the Safety and Patients' Satisfaction Tears Again* in the Treatment of Dry Eye Symptoms

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00535054

Enrollment

125

Registered

2007-09-26

Start date

2007-09-30

Completion date

2010-02-28

Last updated

2010-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Keywords

Dry Eye Syndrome

Brief summary

The purpose of this study is to determine safety and patients' satisfaction when using Tears Again to treat Dry Eye Symptoms.

Interventions

DRUGTears Again

Liposome Eye Spray

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

25 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Suffer from at least two of the following ocular symptoms: burning, stinging, excessive tearing, dryness, grittiness, foreign body sensation ( including patients suffering from blepharitis). * Use artificial tears or any other treatment for these symptoms three or more times a day.

Exclusion criteria

* Known hypersensitivity to Phenoxyethanol. * Pregnant and lactating women. * Receive other ophthalmic medication (except for eyelid hygiene preparations). * Graft-versus-host disease patients. * Participated during the last month in another clinical trial.

Design outcomes

Primary

Measure	Time frame
Schirmer Test, Lissamine Green Test and BUT.	On enrollment and one month later.

Secondary

Measure	Time frame
Questionaire	One, three and four weeks after treatment commencement.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026